KDM1A inactivation causes hereditary food-dependent Cushing syndrome

Archive ouverte

Vaczlavik, Anna | Bouys, Lucas | Violon, Florian | Giannone, Gaetan | Jouinot, Anne | Armignacco, Roberta | Cavalcante, Isadora P | Berthon, Annabel | Letouze, Eric | Vaduva, Patricia | Barat, Maxime | Bonnet, Fideline | Perlemoine, Karine | Ribes, Christopher | Sibony, Mathilde | North, Marie-Odile | Espiard, Stephanie | Emy, Philippe | Haissaguerre, Magalie | Tauveron, Igor | Guignat, Laurence | Groussin, Lionel | Dousset, Bertrand | Reincke, Martin | Fragoso, Maria C | Stratakis, Constantine A | Pasmant, Eric | Libe, Rossella | Assie, Guillaume | Ragazzon, Bruno | Bertherat, Jerome

Edité par CCSD ; Nature Publishing Group -

International audience. PURPOSE: This study aimed to investigate the genetic cause of food-dependent Cushing syndrome (FDCS) observed in patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) and adrenal ectopic expression of the glucose-dependent insulinotropic polypeptide receptor. Germline ARMC5 alterations have been reported in about 25% of PBMAH index cases but are absent in patients with FDCS. METHODS: A multiomics analysis of PBMAH tissues from 36 patients treated by adrenalectomy was performed (RNA sequencing, single-nucleotide variant array, methylome, miRNome, exome sequencing). RESULTS: The integrative analysis revealed 3 molecular groups with different clinical features, namely G1, comprising 16 patients with ARMC5 inactivating variants; G2, comprising 6 patients with FDCS with glucose-dependent insulinotropic polypeptide receptor ectopic expression; and G3, comprising 14 patients with a less severe phenotype. Exome sequencing revealed germline truncating variants of KDM1A in 5 G2 patients, constantly associated with a somatic loss of the KDM1A wild-type allele on 1p, leading to a loss of KDM1A expression both at messenger RNA and protein levels (P = 1.2 × 10(-12) and P < .01, respectively). Subsequently, KDM1A pathogenic variants were identified in 4 of 4 additional index cases with FDCS. CONCLUSION: KDM1A inactivation explains about 90% of FDCS PBMAH. Genetic screening for ARMC5 and KDM1A can now be offered for most PBMAH operated patients and their families, opening the way to earlier diagnosis and improved management.

Suggestions

Du même auteur

KDM1A genetic alterations, a rare cause of primary bilateral macronodular adrenal hyperplasia, strongly associated with food-dependent Cushing's syndrome: results of its systematic germline screening in 301 index cases and genotype/phenotype correlation

Archive ouverte | Bouys, Lucas | CCSD

International audience. Abstract Objective ARMC5 is the most prevalent gene predisposing to primary bilateral macronodular adrenal hyperplasia (PBMAH), but germline KDM1A variants have been identified in the rare PB...

Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma

Archive ouverte | Jouinot, Anne | CCSD

International audience. Design Molecular classification is important for the diagnosis and prognosis of adrenocortical tumors (ACT). Transcriptome profiles separate adrenocortical adenomas ‘C2’ from carcinomas, and ...

Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients

Archive ouverte | Bouys, Lucas | CCSD

International audience. Abstract Objective Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a heterogeneous disease characterized by adrenal macronodules and variable levels of cortisol excess, with not...

Chargement des enrichissements...